News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Gilead Sciences, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Bay
Biotech Investors Bail After Gilead Sciences, Inc. Drug Price Fight
December 24, 2014
·
2 min read
Biotech Bay
Gilead Sciences, Inc.-AbbVie’s Drug Price War Takes Pharma Back To The Future
December 23, 2014
·
1 min read
BioMidwest
Express Scripts Inc. Turns to AbbVie In Huge Hepatitis C Deal; Shuns Gilead Sciences, Inc.
December 22, 2014
·
2 min read
Biotech Bay
Biotech Predictions for Large Cap Firms Include Medivation, Inc., Gilead Sciences, Inc.
December 18, 2014
·
2 min read
Business
Gilead Sciences, Inc. Poaches Genentech Exec To Head Cancer Drug Program
December 15, 2014
·
3 min read
Drug Development
Why Gilead Sciences, Inc. And AbbVie Are Keeping An Eye On Achillion Pharmaceuticals, Inc.
December 12, 2014
·
2 min read
Policy
Gilead Sciences, Inc. Sued Over Outrageous Hepatitis C Drug Prices
December 10, 2014
·
2 min read
Biotech Bay
S.F. Men Shed Condoms In Favor Of Gilead Sciences, Inc.'s HIV Prevention Pill Truvada
December 9, 2014
·
2 min read
Business
Mylan Inc., Gilead Sciences, Inc. Ink Agreement Covering Non-Exclusive TAF Rights
December 1, 2014
·
2 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Policy
FDA Accepts Gilead Sciences, Inc.'s Two NDAs For HIV Therapy
April 21, 2014
·
3 min read
UK Authortity To Spend £18.7 Million To Make Gilead Sciences, Inc.'s Sovaldi Available To Most Grave Patients
April 18, 2014
·
1 min read
Business
Gilead Sciences, Inc. To Release First Quarter 2014 Financial Results On Tuesday, April 22, 2014
April 16, 2014
·
1 min read
Drug Development
Gilead Sciences, Inc.’s Sovaldi® Demonstrates Efficacy And Safety Among Chronic Hepatitis C Patients With Advanced Liver Disease
April 11, 2014
·
1 min read
Biotech Bay
Doctors Welcome Hepatitis C Drug Rivals, Gilead Sciences, Inc. Still Leads
April 11, 2014
·
1 min read
Drug Development
Gilead Sciences, Inc. Announces Phase 2 Results For Two Investigational All-Oral Sofosbuvir-Based Regimens For The Treatment Of Chronic Hepatitis C
April 10, 2014
·
1 min read
Drug Development
Gilead Sciences, Inc. Announces Results From Study Of Sovaldi® For Retreatment Of Chronic Hepatitis C In Patients Not Cured With Prior Antiviral Therapy
April 10, 2014
·
1 min read
Drug Development
Beware Gilead Sciences, Inc., Merck & Co., Inc.'s Hepatitis C Combo Pill Impresses In Phase 2 Trial
April 10, 2014
·
1 min read
BioMidwest
Pharmacy Benefit Manager Express Scripts Inc. Enraged, Looks To Force Gilead Sciences, Inc. To Cut Price Of Sovaldi
April 9, 2014
·
1 min read
Policy
Gilead Sciences, Inc.'s Ledipasvir/Sofosbuvir Fixed-Dose Combo Hep C Tablet Wins FDA Priority Review
April 7, 2014
·
3 min read
